HopeStage
Back to all studies
CompletedNCT01780116

Adherence Support Compared With Usual Care for Schizophrenia

About this titleRead the official source — NCT01780116
Behavioural studyAges 18–65China
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Kwai Chung and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2013
Recruitment status
Completed
Enrollment listed in the registry
134
Sponsor
The Hong Kong Polytechnic University
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
China
Age range
From 18 Years to 65 Years
Official registry ID
NCT01780116
Official title
Show the full official title

An Evaluation of the Effectiveness of Adherence Therapy for Schizophrenia: A Randomized Controlled Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Kwai Chung, Hong Kong · Tuenmen, Hong Kong · China

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is The Hong Kong Polytechnic University, a university.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies